Episode

Biotech euphoria driven by fundamentals

Podcast: Investing Experts
Published: Jul 8, 2026
Duration seconds: 1815
Processing state: not_requested
Canonical source: https://seekingalpha.com/author/investing-experts-podcast?source=ie_podcast:biotech_euphoria
Audio: https://api.spreaker.com/download/episode/72872095/jonathan_f_ie_7_8_7_8_26_10_26_am.mp3
JSON: /v1/public/podcasts/investing-experts-5798955/episodes/biotech-euphoria-driven-by-fundamentals
Markdown: /podcast/investing-experts-5798955/biotech-euphoria-driven-by-fundamentals.md

Actions

POST https://stenobird.com/v1/public/podcasts/investing-experts-5798955/episodes/biotech-euphoria-driven-by-fundamentals/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/investing-experts-5798955/biotech-euphoria-driven-by-fundamentals.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Jonathan Faison, who runs ROTY Biotech Community , says recent biotech euphoria driven by fundamentals and M&A appetite (0:50) 3 $10B+ buyouts with Nuvalent, Apogee, and Crinetics (2:15) Sector ETFs and metrics to focus on (7:00) Bullish on Journey Medical (14:40) Show Notes: Vertex to acquire Crinetics Pharmaceuticals in $10B deal Making Money In Biotech Stocks Episode transcripts For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions